Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Stiftelsen Industrifonden on the investment in Airsonett AB
Mandate

Vinge advises Stiftelsen Industrifonden on the investment in Airsonett AB

August 23, 2007

Industrifonden and SEB will make a joint investment of MSEK 55 and the existing shareholders will invest the remaining MSEK 15 in Airsonett AB, a medical technology company. Airsonett AB carries out research and develops non-pharmaceutical aids reducing the allergen and other air pollution.

Stiftelsen Industrifonden is represented by partner Johan Winnerblad and Johan Larsson.

Related

Vinge has advised Investor in connection with acquisition of shares in EQT

 Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026